Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yidong Li

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
DNA and Cell Biology|December 9, 2003
Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cellsNaijie Jing, Yidong Li, Xuejun Xu, et al.
Breast Cancer Research and Treatment|February 5, 2009
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growthJieying Zhao, Guangchun Chen, Dongmei Cao, et al.
Applied Optics|May 14, 2020
Foveal scanning based on an optical-phases arrayJie Cao, Yidong Li, Dong Zhou, et al.
Molecular Cancer|April 23, 2022
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cellsLei Zhang, Yidong Li, Chaohua Hu, et al.
Cancer Genetics|April 8, 2026
A novel in vitro colorectal cancer model for investigating ABCB1- and ABCC1-mediated multidrug resistanceHarsh Patel, Yidong Li, Xuan-Yu Chen, et al.
Biology of Reproduction|September 10, 2010
Lipopolysaccharide-induced epididymitis disrupts epididymal beta-defensin expression and inhibits sperm motility in ratsDongmei Cao, Yidong Li, Rui Yang, et al.
Experimental Cell Research|December 12, 2025
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: OlverembatinibBohan Zhang, Xiang Chen, Xingduo Dong, et al.
Drug Design, Development and Therapy|December 18, 2025
A Phase I Dose-Escalation Study of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Oral Dose of TigulixostatJun Tao, Shuaibing Liu, Ruijuan Liu, et al.
Molecular Cancer|January 19, 2020
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancerLei Zhang, Yidong Li, Qianchao Wang, et al.
Nature Communications|April 12, 2012
Dissecting a central flip-flop circuit that integrates contradictory sensory cues in C. elegans feeding regulationZhaoyu Li, Yidong Li, Yalan Yi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
DNA and Cell Biology|December 9, 2003
Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cellsNaijie Jing, Yidong Li, Xuejun Xu, et al.
Breast Cancer Research and Treatment|February 5, 2009
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growthJieying Zhao, Guangchun Chen, Dongmei Cao, et al.
Applied Optics|May 14, 2020
Foveal scanning based on an optical-phases arrayJie Cao, Yidong Li, Dong Zhou, et al.
Molecular Cancer|April 23, 2022
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cellsLei Zhang, Yidong Li, Chaohua Hu, et al.
Cancer Genetics|April 8, 2026
A novel in vitro colorectal cancer model for investigating ABCB1- and ABCC1-mediated multidrug resistanceHarsh Patel, Yidong Li, Xuan-Yu Chen, et al.
Biology of Reproduction|September 10, 2010
Lipopolysaccharide-induced epididymitis disrupts epididymal beta-defensin expression and inhibits sperm motility in ratsDongmei Cao, Yidong Li, Rui Yang, et al.
Experimental Cell Research|December 12, 2025
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: OlverembatinibBohan Zhang, Xiang Chen, Xingduo Dong, et al.
Drug Design, Development and Therapy|December 18, 2025
A Phase I Dose-Escalation Study of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Oral Dose of TigulixostatJun Tao, Shuaibing Liu, Ruijuan Liu, et al.
Molecular Cancer|January 19, 2020
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancerLei Zhang, Yidong Li, Qianchao Wang, et al.
Nature Communications|April 12, 2012
Dissecting a central flip-flop circuit that integrates contradictory sensory cues in C. elegans feeding regulationZhaoyu Li, Yidong Li, Yalan Yi, et al.
Pageof 4